Inhalation Sciences secures important IP rights
(Stockholm 29 October, 2020) Swedish medtech innovator Inhalation Sciences Sweden AB (publ), forerunner in the development of next-generation labtech equipment for inhalation research, secures important IP rights for its state-of-the-art laboratory system PreciseInhale[®]. The unique system allows scientists to work with several different preclinical services based on PreciseInhale and measure how inhaled particles act in our lungs and affect our health.Inhalation Sciences Sweden AB reports the following IP-related events. Important patent secured in the US for PreciseInhale[®]Today’s